Item 8.01 Other Events.
On March 18, 2021, ITAC
issued a press release announcing the execution of a definitive Business Combination Agreement, dated as of March 18, 2021 (the
“Business Combination Agreement”), with Arbe Robotics Ltd., an Israeli company ("Arbe") and
leading provider of next-generation 4D Imaging Radar solutions. Pursuant to the Business Combination Agreement, subject to the
terms and conditions set forth therein, a newly formed Delaware subsidiary of Arbe will merge with and into ITAC, with ITAC surviving
as a wholly-owned subsidiary of Arbe. A copy of the press release is furnished as Exhibit 99.3 to this Current Report on Form 8-K.
Forward-Looking Statements
This report contains, and certain
oral statements made by representatives of ITAC and Arbe and their respective affiliates, from time to time may contain, “forward-looking
statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act
of 1995. ITAC’s and Arbe’s actual results may differ from their expectations, estimates and projections and consequently,
you should not rely on these forward-looking statements as predictions of future events. Words such as “expect,” “estimate,”
“project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,”
“may,” “will,” “could,” “should,” “believes,” “predicts,”
“potential,” “might” and “continues,” and similar expressions are intended to identify such
forward-looking statements. These forward-looking statements include, without limitation, ITAC’s and Arbe’s expectations
with respect to future performance and anticipated financial impacts of the transactions (the “Transactions”)
contemplated by the Business Combination Agreement, the satisfaction of the closing conditions to the Transactions and the timing
of the completion of the Transactions. These forward-looking statements involve significant risks and uncertainties that could
cause actual results to differ materially from expected results. Most of these factors are outside of the control of ITAC or Arbe
and are difficult to predict. Factors that may cause such differences include but are not limited to: (i) the expected timing and
likelihood of completion of the Transactions, including the risk that the Transactions may not close due to one or more closing
conditions to the Transactions in the Business Combination Agreement not being satisfied or waived on a timely basis or otherwise,
or that the required approval of the Business Combination Agreement and related matters by the shareholders of Arbe and ITAC are
not obtained; (ii) a default by one or more of the investors in the PIPE on its commitment, and ITAC’s failure to retain
sufficient cash in its trust account or find replacement financing in order to meet the $100 million minimum cash condition in
the Business Combination Agreement; (iii) the occurrence of any event, change or other circumstances that could give rise to the
termination of the Business Combination Agreement; (iv) the ability of Arbe to meet Nasdaq listing standards following the Transactions
and in connection with the consummation thereof; (v) costs related to the proposed Transactions; (vi) the occurrence of a material
adverse change with respect to the financial position, performance, operations or prospects of Arbe or ITAC; (vi) the disruption
of Arbe management time from ongoing business operations due to the proposed Transactions; (vii) announcements relating to the
Transactions having an adverse effect on the market price of ITAC's securities; (viii) the effect of the Transactions and the announcement
thereof on the ability of Arbe to retain customers and retain and hire key personnel and maintain relationships with its suppliers
and customers and on its operating results and businesses generally; (ix) the failure of Arbe to meet projected development and
production targets; (x) changes in applicable laws or regulations, including laws and regulations affecting the market for Arbe’s
products; (xi) the possibility that the combined company may be adversely affected by other economic, business, and/or competitive
factors, or the continuing effects of the COVID-19 pandemic, the worsening thereof or other future pandemics; and (xii) other risks
and uncertainties described herein, as well as those risks and uncertainties discussed from time to time in other reports and other
public filings with the Securities and Exchange Commission (the “SEC”) by ITAC or Arbe. The foregoing list of factors
is not exclusive. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect,
actual results may vary materially from those indicated or anticipated by such forward-looking statements. Readers are cautioned
not to place undue reliance upon any forward-looking statements, which speak only as of the date made. ITAC and Arbe undertake
no obligation to update forward-looking statements to reflect events or circumstances after the date they were made except as required
by law or applicable regulation.
Readers are referred to the most recent
reports filed with the SEC by ITAC. Readers are cautioned not to place undue reliance upon any forward-looking statements, which
speak only as of the date made, and ITAC undertakes no obligation to update or revise the forward-looking statements, whether as
a result of new information, future events or otherwise.
Important Information About the
Transactions and Where to Find It
Arbe intends to file with the SEC a Registration
Statement on Form F-4, which will include a proxy statement of ITAC that constitutes a prospectus for Arbe and a definitive proxy
statement for ITAC’s shareholders. Promptly after filing its definitive proxy statement with the SEC, ITAC will mail the
definitive proxy statement and a proxy card to each stockholder entitled to vote at the special meeting relating to the Transactions.
Investors and securityholders of ITAC and other interested persons are advised to read, when available, the preliminary proxy statement,
and amendments thereto, and the definitive proxy statement in connection with ITAC’s solicitation of proxies for the special
meeting to be held to approve the Business Combination Agreement and the Transactions because these documents will contain important
information about ITAC, Arbe, the Business Combination Agreement and the Transactions. The definitive proxy statement will be mailed
to securityholders of ITAC as of a record date to be established for voting on the Business Combination Agreement and the Transactions.
The definitive proxy statement, the preliminary proxy statement and other relevant materials in connection with the transaction
(when they become available), and any other documents filed by ITAC with the SEC, may be obtained free of charge at the SEC's website
(www.sec.gov) or by writing to ITAC at: 5090 Richmond Ave., Suite 319; Houston TX, 77056.
Participants in the Solicitation
Arbe, ITAC, and their respective directors,
executive officers and employees and other persons may be deemed to be participants in the solicitation of proxies from the holders
of ITAC common stock in respect of the proposed Transactions. Information about ITAC's directors and executive officers and their
ownership of ITAC's common stock is set forth in ITAC's filings with the SEC. Additional information regarding the interests of
the participants in the proxy solicitation will be included in the proxy statement pertaining to the proposed Transactions when
it becomes available. These documents can be obtained free of charge from the sources indicated above.
Disclaimer
This communication shall not constitute
an offer to sell or the solicitation of an offer to buy any securities pursuant to the proposed transactions or otherwise, nor
shall there be any sale of securities in any jurisdiction in which the offer, solicitation or sale would be unlawful prior to the
registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made except
by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended.